NO FEE UNLESS WE WIN
FREE CASE REVIEW

Free Consultation
Call Now

817-870-2102

Diabetes Drugs Carry Vision Risks

On June 11, 2012, the New York Times released an article concerning a recent study published by The Archives of Internal Medicine indicating that a certain type of drug used for treatment of Type 2 diabetes may lead to an increased risk for vision problems, including blindness.

Voluntary Market Withdrawal of Hip Component

On June 1, 2012, Smith & Nephew, an orthopedic firm headquartered in the U.K., issued a press release stating that the company is voluntarily recalling an optional metal liner used in its all-metal hip system, the R3 Acetabular System.

DePuy ASR MDL Litigation Update

A DePuy ASR Multi-district litigation status conference was held on Tuesday, June 5, 2012 at the U.S. District courthouse in Philadelphia, Pennsylvania.

Multidistrict Consolidation Sought in Pradaxa Litigation

A motion was filed on May 30, 2012 with the United States Judicial Panel on Multidistrict Litigation (JPML) petitioning for the creation of a coordinated federal MDL for all cases concerning the anticoagulant drug Pradaxa (dabigatran etexilate mesylate). The motion seeks to transfer pending cases and future claims relating to Pradaxa to the United States […]

Health Canada Issued Public Communication on Metal-on-Metal Hip Implants

On May 9, 2012, Health Canada issued an announcement regarding a recent letter disseminated by the agency to Canadian orthopedic surgeons. Health Canada is the federal department that is responsible for overseeing public health in the country. In the letter, Health Canada advises orthopedic surgeons of the possible risks posed by metal-on-metal total hip devices.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.